PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139 | -28.0% | 13,394 | -0.3% | 0.00% | – |
| Q2 2023 | $193 | +78.7% | 13,432 | -10.9% | 0.00% | – |
| Q1 2023 | $108 | -35.7% | 15,068 | +0.8% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 14,950 | +2.2% | 0.00% | – |
| Q3 2022 | $163,000 | +87.4% | 14,635 | +41.5% | 0.00% | – |
| Q2 2022 | $87,000 | -96.8% | 10,340 | -87.2% | 0.00% | – |
| Q4 2020 | $2,692,000 | -47.7% | 81,021 | -42.3% | 0.00% | -100.0% |
| Q3 2020 | $5,151,000 | -11.8% | 140,462 | -20.8% | 0.00% | 0.0% |
| Q2 2020 | $5,837,000 | – | 177,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |